Literature DB >> 15036353

Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical.

Sergey I Dikalov1, Michael P Vitek, Ronald P Mason.   

Abstract

A growing body of evidence supports an important role for oxidative stress in the pathogenesis of Alzheimer's disease. Recently, a number of papers have shown a synergistic neurotoxicity of amyloid beta peptide and cupric ions. We hypothesized that complexes of cupric ions with neurotoxic amyloid beta peptides (Abeta) can stimulate copper-mediated free radical formation. We found that neurotoxic Abeta (1-42), Abeta (1-40), and Abeta (25-35) stimulated copper-mediated oxidation of ascorbate, whereas nontoxic Abeta (40-1) did not. Formation of ascorbate free radical was significantly increased by Abeta (1-42) in the presence of ceruloplasmin. Once cupric ion is reduced to cuprous ion, it can be oxidized by oxygen to generate superoxide radical or it can react with hydrogen peroxide to form hydroxyl radical. Hydrogen peroxide greatly increased the oxidation of cyclic hydroxylamines and ascorbate by cupric-amyloid beta peptide complexes, implying redox cycling of copper ions. Using the spin-trapping technique, we have shown that toxic amyloid beta peptides led to a 4-fold increase in copper-mediated hydroxyl radical formation. We conclude that toxic Abeta peptides do indeed stimulate copper-mediated oxidation of ascorbate and generation of hydroxyl radicals. Therefore, cupric-amyloid beta peptide-stimulated free radical generation may be involved in the pathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036353     DOI: 10.1016/j.freeradbiomed.2003.11.004

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  25 in total

Review 1.  Metals, oxidative stress and neurodegenerative disorders.

Authors:  Klaudia Jomova; Dagmar Vondrakova; Michael Lawson; Marian Valko
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

2.  Production of extracellular superoxide by human lymphoblast cell lines: comparison of electron spin resonance techniques and cytochrome C reduction assay.

Authors:  Sergey I Dikalov; Wei Li; Payam Mehranpour; Shaoshan S Wang; A Maziar Zafari
Journal:  Biochem Pharmacol       Date:  2006-12-15       Impact factor: 5.858

Review 3.  Control of DNA integrity in skeletal muscle under physiological and pathological conditions.

Authors:  Yara Bou Saada; Vlada Zakharova; Boris Chernyak; Carla Dib; Gilles Carnac; Svetlana Dokudovskaya; Yegor S Vassetzky
Journal:  Cell Mol Life Sci       Date:  2017-04-25       Impact factor: 9.261

4.  Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection.

Authors:  Douglas Ganini; Donatella Canistro; JinJie Jiang; JinJie Jang; Krisztian Stadler; Ronald P Mason; Maria B Kadiiska
Journal:  Free Radic Biol Med       Date:  2012-07-21       Impact factor: 7.376

5.  Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

Authors:  Willam T Wang; Breeya A Tailor; David S Cohen; Xudong Huang
Journal:  EC Pharmacol Toxicol       Date:  2019-06-21

Review 6.  Alpha-crystallin-derived peptides as therapeutic chaperones.

Authors:  Murugesan Raju; Puttur Santhoshkumar; K Krishna Sharma
Journal:  Biochim Biophys Acta       Date:  2015-07-02

7.  Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.

Authors:  Sudhakar Parthasarathy; Brian Yoo; Dan McElheny; William Tay; Yoshitaka Ishii
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

8.  Hydroxyl radical oxidation of guanosine 5'-triphosphate (GTP): requirement for a GTP-Cu(II) complex.

Authors:  Giselle Cerchiaro; Celeste Bolin; Fernando Cardozo-Pelaez
Journal:  Redox Rep       Date:  2009       Impact factor: 4.412

Review 9.  Therapeutics for Alzheimer's disease based on the metal hypothesis.

Authors:  Ashley I Bush; Rudolph E Tanzi
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

10.  Catalytic therapy of cancer with ascorbate and extracts of medicinal herbs.

Authors:  Nadejda Rozanova Torshina; Jin Z Zhang; Diane E Heck
Journal:  Evid Based Complement Alternat Med       Date:  2007-12-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.